132 related articles for article (PubMed ID: 24949602)
1. Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands.
Mulder CJ; van Asseldonk DP; de Boer NK
J Gastrointestin Liver Dis; 2014 Jun; 23(2):123-5. PubMed ID: 24949602
[No Abstract] [Full Text] [Related]
2. Finding hidden treasures in old drugs: the challenges and importance of licensing generics.
Simsek M; Meijer B; van Bodegraven AA; de Boer NKH; Mulder CJJ
Drug Discov Today; 2018 Jan; 23(1):17-21. PubMed ID: 28867540
[TBL] [Abstract][Full Text] [Related]
3. [Continued development of drugs: the path of thioguanine].
Simsek M; de Boer NKH; Mulder CJJ
Ned Tijdschr Geneeskd; 2018; 162():D1757. PubMed ID: 29350120
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
5. PhRMA: Placing Prescription Drugs into Context.
Lindsley CW
ACS Chem Neurosci; 2016 Oct; 7(10):1312. PubMed ID: 27756135
[No Abstract] [Full Text] [Related]
6. Patient-Reported Experiences with a Relicensed Generic: Thioguanine for the Treatment of Inflammatory Bowel Diseases.
Simsek M; Markus-de Kwaadsteniet TML; van der Horst D; Mulder CJJ; de Boer NKH
J Gastrointestin Liver Dis; 2018 Dec; 27(4):385-389. PubMed ID: 30574620
[TBL] [Abstract][Full Text] [Related]
7. Drifting policies are wasting billions.
Suh GH
Int Psychogeriatr; 2012 Mar; 24(3):343-5. PubMed ID: 22078134
[No Abstract] [Full Text] [Related]
8. Inadequately met needs.
Nat Biotechnol; 2011 May; 29(5):371. PubMed ID: 21552219
[No Abstract] [Full Text] [Related]
9. An Indian effort towards affordable drugs: "generic to designer drugs".
Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
[No Abstract] [Full Text] [Related]
10. 13th EGA annual conference. Challenges in the European and global environment for the generic medicines industry.
Kuhrt K
IDrugs; 2007 Aug; 10(8):549-53. PubMed ID: 17665329
[No Abstract] [Full Text] [Related]
11. Can you teach old drugs new tricks?
Nosengo N
Nature; 2016 Jun; 534(7607):314-6. PubMed ID: 27306171
[No Abstract] [Full Text] [Related]
12. Busting the billion-dollar myth: how to slash the cost of drug development.
Maxmen A
Nature; 2016 Aug; 536(7617):388-90. PubMed ID: 27558048
[No Abstract] [Full Text] [Related]
13. Skies darken over drug companies.
Holmes D
Lancet; 2012 May; 379(9829):1863-4. PubMed ID: 22616103
[No Abstract] [Full Text] [Related]
14. Cheap and cheerful.
Munro R
Nurs Times; 2000 Jan 20-26; 96(3):16. PubMed ID: 11961788
[No Abstract] [Full Text] [Related]
15. [Systematic off-label use of drugs].
Høeg E; Frostelid T
Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1452-3. PubMed ID: 20706302
[No Abstract] [Full Text] [Related]
16. Prescription drug prices in the US.
Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
[No Abstract] [Full Text] [Related]
17. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.
Emanuele E
South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163
[No Abstract] [Full Text] [Related]
18. Pharmaceutical R&D: an age of change?
Baldwin JJ
Future Med Chem; 2014 Jun; 6(10):1109-12. PubMed ID: 25078132
[No Abstract] [Full Text] [Related]
19. Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance.
Bloom BE
Assay Drug Dev Technol; 2015 Dec; 13(10):606-11. PubMed ID: 26284286
[TBL] [Abstract][Full Text] [Related]
20. Drug Regulation and Pricing--Can Regulators Influence Affordability?
Eichler HG; Hurts H; Broich K; Rasi G
N Engl J Med; 2016 May; 374(19):1807-9. PubMed ID: 27168431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
